By expenditures
| Name | Title | Type |
|---|---|---|
| Carolyn Kasdorf | Interim Vice President for Business and Finance / Chief Financial Officer | Auditee |
| Alan D. Bowers, Jr. | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 365884 | 2023 | 2025-09-09 | Carr Riggs & Ingram | $2.06M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 365884 | 2023 | 2025-09-09 | 1152436 | 2023-009 | Significant Deficiency | - | F |
| 365884 | 2023 | 2025-09-09 | 1152435 | 2023-008 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 1152434 | 2023-007 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 1152433 | 2023-006 | Material Weakness | - | AB |
| 365884 | 2023 | 2025-09-09 | 1152432 | 2023-005 | Significant Deficiency | - | ABC |
| 365884 | 2023 | 2025-09-09 | 1152431 | 2023-009 | Significant Deficiency | - | F |
| 365884 | 2023 | 2025-09-09 | 1152430 | 2023-008 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 1152429 | 2023-007 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 1152428 | 2023-006 | Material Weakness | - | AB |
| 365884 | 2023 | 2025-09-09 | 1152427 | 2023-005 | Significant Deficiency | - | ABC |
| 365884 | 2023 | 2025-09-09 | 1152426 | 2023-009 | Significant Deficiency | - | F |
| 365884 | 2023 | 2025-09-09 | 1152425 | 2023-008 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 1152424 | 2023-007 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 1152423 | 2023-006 | Material Weakness | - | AB |
| 365884 | 2023 | 2025-09-09 | 1152422 | 2023-005 | Significant Deficiency | - | ABC |
| 365884 | 2023 | 2025-09-09 | 1152421 | 2023-009 | Significant Deficiency | - | F |
| 365884 | 2023 | 2025-09-09 | 1152420 | 2023-008 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 1152419 | 2023-007 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 1152418 | 2023-006 | Material Weakness | - | AB |
| 365884 | 2023 | 2025-09-09 | 1152417 | 2023-005 | Significant Deficiency | - | ABC |
| 365884 | 2023 | 2025-09-09 | 575994 | 2023-009 | Significant Deficiency | - | F |
| 365884 | 2023 | 2025-09-09 | 575993 | 2023-008 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 575992 | 2023-007 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 575991 | 2023-006 | Material Weakness | - | AB |
| 365884 | 2023 | 2025-09-09 | 575990 | 2023-005 | Significant Deficiency | - | ABC |
| 365884 | 2023 | 2025-09-09 | 575989 | 2023-009 | Significant Deficiency | - | F |
| 365884 | 2023 | 2025-09-09 | 575988 | 2023-008 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 575987 | 2023-007 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 575986 | 2023-006 | Material Weakness | - | AB |
| 365884 | 2023 | 2025-09-09 | 575985 | 2023-005 | Significant Deficiency | - | ABC |
| 365884 | 2023 | 2025-09-09 | 575984 | 2023-009 | Significant Deficiency | - | F |
| 365884 | 2023 | 2025-09-09 | 575983 | 2023-008 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 575982 | 2023-007 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 575981 | 2023-006 | Material Weakness | - | AB |
| 365884 | 2023 | 2025-09-09 | 575980 | 2023-005 | Significant Deficiency | - | ABC |
| 365884 | 2023 | 2025-09-09 | 575979 | 2023-009 | Significant Deficiency | - | F |
| 365884 | 2023 | 2025-09-09 | 575978 | 2023-008 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 575977 | 2023-007 | Significant Deficiency | - | I |
| 365884 | 2023 | 2025-09-09 | 575976 | 2023-006 | Material Weakness | - | AB |
| 365884 | 2023 | 2025-09-09 | 575975 | 2023-005 | Significant Deficiency | - | ABC |